Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Comparison Results
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$24.94
HK$39.86B
-22.62
83.11%
1 Buy
1 Hold
0 Sell
Moderate Buy
Zai Lab Ltd
HK$16.25
HK$18.39B
-10.93
-25.46%
8 Buy
1 Hold
0 Sell
Strong Buy
Alphamab Oncology
HK$9.39
HK$9.15B
-76.25
58.35%
1 Buy
0 Hold
0 Sell
Moderate Buy
RemeGen Co. Ltd. Class H
HK$106.00
HK$76.84B
51.47
254.52%
6 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Henlius Biotech, Inc. Class H
HK$83.35
HK$45.30B
34.57
220.58%
6 Buy
0 Hold
0 Sell
Strong Buy
Ascentage Pharma Group International
HK$50.90
HK$18.20B
-13.81
39.60%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
24.94
9.76
64.30%
HK:9688
Zai Lab Ltd
16.25
-8.10
-33.26%
HK:9966
Alphamab Oncology
9.39
2.74
41.20%
HK:9995
RemeGen Co. Ltd. Class H
106.00
75.80
250.99%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
83.35
53.00
174.63%
HK:6855
Ascentage Pharma Group International
49.14
10.64
27.64%